Diabetes, Vol 39, Issue 5 583-589, Copyright © 1990 by American Diabetes Association

ARTICLES

Prevention of type I diabetes in NOD mice by adjuvant immunotherapy

MW Sadelain, HY Qin, J Lauzon and B Singh
Department of Immunology, University of Alberta, Edmonton, Canada.

The nonobese diabetic (NOD) mouse is an excellent model of insulin-dependent (type I) human diabetes mellitus. We report that a single injection of complete Freund's adjuvant (CFA) given at an early age (5 wk) prevented the appearance of diabetes and greatly increased the life span of NOD mice without additional therapy. No treated mouse developed hyperglycemia by the age of 12 mo (n = 13), whereas all untreated mice died of diabetes before 8 mo of age (n = 38). All CFA-treated mice were alive and healthy at 12 mo of age. Some CFA-treated NOD mice that were monitored for long-term survival are still alive with no sign of disease at 18 mo of age (n = 5). Administration of CFA resulted in decreased in vitro splenic lymphocyte proliferative responses to alloantigen and mitogen. Cell-mixing experiments indicated that antigen-nonspecific inhibitory cells were elicited in the spleen and increased in the bone marrow. These regulatory cells were Thy-1- and nonadherent to nylon wool, as has been described for natural suppressor (NS) cells. These data lend support to a relationship between the boosting of endogenous NS activity and the establishment of tolerance to self in the context of autoimmunity. Our results suggest that early nonspecific immunotherapy of genetically predisposed individuals could prevent the development of autoimmune diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. A. Saunders, T. Raine, A. Cooke, and C. E. Lawrence Inhibition of Autoimmune Type 1 Diabetes by Gastrointestinal Helminth Infection Infect. Immun., January 1, 2007; 75(1): 397 - 407. [Abstract] [Full Text] [PDF]

				A. Suri and E. R Unanue Response to Comment on Suri et al. on Diabetes Reversal in NOD Mice Science, November 24, 2006; 314(5803): 1243d - 1243d. [Abstract] [Full Text] [PDF]

				D. Ly, Q.-S. Mi, S. Hussain, and T. L. Delovitch Protection from Type 1 Diabetes by Invariant NK T Cells Requires the Activity of CD4+CD25+ Regulatory T Cells J. Immunol., September 15, 2006; 177(6): 3695 - 3704. [Abstract] [Full Text] [PDF]

				D. A. Melton Reversal of type 1 diabetes in mice. N. Engl. J. Med., July 6, 2006; 355(1): 89 - 90. [Full Text] [PDF]

				H.-Y. Qin, R. Mukherjee, E. Lee-Chan, C. Ewen, R. C. Bleackley, and B. Singh A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity Int. Immunol., July 1, 2006; 18(7): 1001 - 1015. [Abstract] [Full Text] [PDF]

				J. Chen, Y.-G. Chen, P. C. Reifsnyder, W. H. Schott, C.-H. Lee, M. Osborne, F. Scheuplein, F. Haag, F. Koch-Nolte, D. V. Serreze, et al. Targeted Disruption of CD38 Accelerates Autoimmune Diabetes in NOD/Lt Mice by Enhancing Autoimmunity in an ADP-Ribosyltransferase 2-Dependent Fashion. J. Immunol., April 15, 2006; 176(8): 4590 - 4599. [Abstract] [Full Text] [PDF]

				J. Nishio, J. L. Gaglia, S. E. Turvey, C. Campbell, C. Benoist, and D. Mathis Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science, March 24, 2006; 311(5768): 1775 - 1778. [Abstract] [Full Text] [PDF]

				A. Suri, B. Calderon, T. J. Esparza, K. Frederick, P. Bittner, and E. R. Unanue Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science, March 24, 2006; 311(5768): 1778 - 1780. [Abstract] [Full Text] [PDF]

				B. Zhu, I. Guleria, A. Khosroshahi, T. Chitnis, J. Imitola, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis J. Immunol., March 15, 2006; 176(6): 3480 - 3489. [Abstract] [Full Text] [PDF]

				A. M. Marleau and N. Sarvetnick T cell homeostasis in tolerance and immunity J. Leukoc. Biol., September 1, 2005; 78(3): 575 - 584. [Abstract] [Full Text] [PDF]

				M. Huppmann, A. Baumgarten, A.-G. Ziegler, and E. Bonifacio Neonatal Bacille Calmette-Guerin Vaccination and Type 1 Diabetes Diabetes Care, May 1, 2005; 28(5): 1204 - 1206. [Full Text] [PDF]

				D. A. Mahamed, A. Marleau, M. Alnaeeli, B. Singh, X. Zhang, J. M. Penninger, and Y.-T. A. Teng G(-) Anaerobes-Reactive CD4+ T-Cells Trigger RANKL-Mediated Enhanced Alveolar Bone Loss in Diabetic NOD Mice Diabetes, May 1, 2005; 54(5): 1477 - 1486. [Abstract] [Full Text] [PDF]

				H. Kared, A. Masson, H. Adle-Biassette, J.-F. Bach, L. Chatenoud, and F. Zavala Treatment With Granulocyte Colony-Stimulating Factor Prevents Diabetes in NOD Mice by Recruiting Plasmacytoid Dendritic Cells and Functional CD4+CD25+ Regulatory T-Cells Diabetes, January 1, 2005; 54(1): 78 - 84. [Abstract] [Full Text] [PDF]

				H.-Y. Qin, P. Chaturvedi, and B. Singh In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-{gamma}/TNF-{alpha} Int. Immunol., December 1, 2004; 16(12): 1723 - 1732. [Abstract] [Full Text] [PDF]

				I-F. Lee, H. Qin, J. Trudeau, J. Dutz, and R. Tan Regulation of Autoimmune Diabetes by Complete Freund's Adjuvant Is Mediated by NK Cells J. Immunol., January 15, 2004; 172(2): 937 - 942. [Abstract] [Full Text] [PDF]

				W. H. Schott, B. D. Haskell, H. M. Tse, M. J. Milton, J. D. Piganelli, C. M. Choisy-Rossi, P. C. Reifsnyder, A. V. Chervonsky, and E. H. Leiter Caspase-1 Is Not Required for Type 1 Diabetes in the NOD Mouse Diabetes, January 1, 2004; 53(1): 99 - 104. [Abstract] [Full Text] [PDF]

				D. S. Riminton, R. Kandasamy, D. Dravec, A. Basten, and A. G. Baxter Dermal Enhancement: Bacterial Products on Intact Skin Induce and Augment Organ-Specific Autoimmune Disease J. Immunol., January 1, 2004; 172(1): 302 - 309. [Abstract] [Full Text] [PDF]

				J. F. Elliott, J. Liu, Z.-N. Yuan, N. Bautista-Lopez, S. L. Wallbank, K. Suzuki, D. Rayner, P. Nation, M. A. Robertson, G. Liu, et al. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IA{beta} knockout NOD mice PNAS, November 11, 2003; 100(23): 13447 - 13452. [Abstract] [Full Text] [PDF]

				F. J. Quintana, M. Pitashny, and I. R. Cohen Experimental autoimmune myasthenia gravis in naive non-obese diabetic (NOD/LtJ) mice: susceptibility associated with natural IgG antibodies to the acetylcholine receptor Int. Immunol., January 1, 2003; 15(1): 11 - 16. [Abstract] [Full Text] [PDF]

				J.-F. Bach The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases N. Engl. J. Med., September 19, 2002; 347(12): 911 - 920. [Full Text] [PDF]

				K. V. Tarbell, M. Lee, E. Ranheim, C. C. Chao, M. Sanna, S.-K. Kim, P. Dickie, L. Teyton, M. Davis, and H. McDevitt CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer J. Exp. Med., August 19, 2002; 196(4): 481 - 492. [Abstract] [Full Text] [PDF]

				A. Quinn, M. F. McInerney, and E. E. Sercarz MHC Class I-Restricted Determinants on the Glutamic Acid Decarboxylase 65 Molecule Induce Spontaneous CTL Activity J. Immunol., August 1, 2001; 167(3): 1748 - 1757. [Abstract] [Full Text] [PDF]

				D. A. Kahn, D. C. Archer, D. P. Gold, and C. J. Kelly Adjuvant Immunotherapy Is Dependent on Inducible Nitric Oxide Synthase J. Exp. Med., June 4, 2001; 193(11): 1261 - 1268. [Abstract] [Full Text] [PDF]

				C. Carnaud, J.-M. Gombert, O. Donnars, H.-J. Garchon, and A. Herbelin Protection Against Diabetes and Improved NK/NKT Cell Performance in NOD.NK1.1 Mice Congenic at the NK Complex J. Immunol., February 15, 2001; 166(4): 2404 - 2411. [Abstract] [Full Text] [PDF]

				D. J. Becker, R. E. LaPorte, I. Libman, M. Pietropaolo, and H.-M. Dosch Prevention of Type 1 Diabetes: Is Now the Time? J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 498 - 506. [Full Text]

				G. Fossati, A. Cooke, R. Q. Papafio, K. Haskins, and B. Stockinger Triggering a Second T Cell Receptor on Diabetogenic T Cells Can Prevent Induction of Diabetes J. Exp. Med., August 16, 1999; 190(4): 577 - 584. [Abstract] [Full Text] [PDF]

				E. Bonifacio, M. Scirpoli, K. Kredel, M. Fuchtenbusch, and A.-G. Ziegler Early Autoantibody Responses in Prediabetes Are IgG1 Dominated and Suggest Antigen-Specific Regulation J. Immunol., July 1, 1999; 163(1): 525 - 532. [Abstract] [Full Text] [PDF]

				B. Balasa, J. D. Davies, J. Lee, A. Good, B. T. Yeung, and N. Sarvetnick IL-10 Impacts Autoimmune Diabetes Via a CD8+ T Cell Pathway Circumventing the Requirement for CD4+ T and B Lymphocytes J. Immunol., October 15, 1998; 161(8): 4420 - 4427. [Abstract] [Full Text] [PDF]

				R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text]

				D. Faustman, X. Li, H. Y. Lin, R. Huang, and J. Guo Response Science, June 26, 1992; 256(5065): 1830 - 1831. [PDF]